The point of care diagnostics market is poised to grow by USD 10.69 billion during 2020-2024, decelerating at a CAGR of over 10% during the forecast period.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201130005629/en/
Technavio has announced its latest market research report titled Global Point of Care (POC) Diagnostics Market 2020-2024 (Graphic: Business Wire)
Worried about the impact of COVID-19 on your Business? Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get FREE Sample Report in Minutes!
The report on the point of care diagnostics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the growing geriatric population.
The point of care diagnostics market analysis includes the product, end-user, and geography landscape. This study identifies the shift from conventional testing methods to rapid diagnostics as one of the prime reasons driving the point of care diagnostics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The point of care diagnostics market covers the following areas:
Point Of Care Diagnostics Market Sizing
Point Of Care Diagnostics Market Forecast
Point Of Care Diagnostics Market Analysis
Companies Mentioned
- Abbott Laboratories
- Becton, Dickinson and Co.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- PTS Diagnostics
- QIAGEN NV
- Sekisui Chemical Co. Ltd.
- Siemens Healthineers AG
- Trinity Biotech Plc
Related Reports on Health Care Include:
Global Point-of-Care Coagulation Testing Market - Global point-of-care coagulation testing market is segmented by end-user (Hospitals and clinics and Homecare) and geographic landscape (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
Global Molecular Point of Care Devices Market - Global molecular point of care devices market is segmented by application (infectious diseases, oncology, and others) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
Key Topics Covered:
Executive Summary
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Hematology diagnostics - Market size and forecast 2019-2024
- Infectious disease diagnostics - Market size and forecast 2019-2024
- Rapid cardiovascular diagnostics - Market size and forecast 2019-2024
- Rapid coagulation diagnostics - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals and clinics - Market size and forecast 2019-2024
- Homecare settings - Market size and forecast 2019-2024
- Clinical diagnostic laboratories - Market size and forecast 2019-2024
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Volume drivers – Demand led growth
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- PerkinElmer Inc.
- PTS Diagnostics
- QIAGEN NV
- Sekisui Chemical Co. Ltd.
- Siemens Healthineers AG
- Trinity Biotech Plc
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201130005629/en/
Contacts:
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/